There was a placebo-controlled study published in 2005 on Potaba which showed that this drug halted progression of Peyronie’s. Based on this data for those who tolerate Potaba, would this not be a reasonable addition to a verapamil injection and/or verapamil iontophoresis regimen? Would there be any contraindications to this?

How Can We Help?
< Back
You are here:
Print

You are clearly doing your homework investigating the research on Potaba which was a very well conducted placebo-controlled trial. This study did show stabilization of the disease and some reduction in plaque size in those patients who received Potaba, but there was no evidence of improvement of deformity. In my opinion, if this drug were inexpensive, caused no side effects, and did not require ingesting 24 tablets a day, it may be worth considering. But given that there is no improvement in deformity, in my opinion there is little evidence of benefit with this agent, and the cost, side effects, and large number of tablets make the consumption of the drug inconvenient. I am therefore not a fan of using Potaba at all. There is certainly no contraindication to using this combination with verapamil or interferon injections, but I think other oral agents may make more sense such as pentoxifylline and L-arginine.

Previous There have been 2 recent studies done on the effectiveness of traction devices at reducing curvature. Paolo Gontero, et al reported an average curvature reduction of 4 degrees. Levine, et al reported an average curvature reduction of 15 degrees. The duration of both studies was 6 months and the hours of use per day was similar. What accounts for the large difference in results between the 2 studies?
Next What are the frequency and dosage characteristics of verapamil? Can injections cause further damage (plaque)?
Table of Contents